Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.90
(
1.05%
)
US TECH 100
26,103.20
(
-0.39%
)
Dow Jones
49,490.03
(
0.00%
)
Brent Oil
98.33
(
1.66%
)
Bitcoin
77,546.84
(
-0.88%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

swg_tdr

Send PM Follow Ignore
Followers 22
Posts 1805
Boards Moderated 0
Alias Born 01/04/2003

swg_tdr

Re: biopharm post# 319717

Wednesday, 02/07/2018 5:20:39 PM

Wednesday, February 07, 2018 5:20:39 PM

Post# of 347009
$200B, BULL, as of Nov 2016, Illumina remains the leader in its industry, and management believes that the genomic testing market could eventually exceed $20 billion in annual sales.”

www.biospace.com/article/how-illumina-stacks-up-against-b-warren-buffet-s-b-acquisition-criteria-/

most of the early cancer detection testing now goes genomics
IMO
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote